Therefore, one follow-up study would be to propose a harmonized prediction/stratification method that uses PRS scores and other possible factors that can be effective in BC prediction, such as the existence of BRCA1 or BRCA2 variants and/or some other clinical measures to obtain better prediction performances. The gene discussed is BRCA1; the disease is breast cancer.